SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-290995
Filing Date
2019-11-13
Accepted
2019-11-13 16:09:05
Documents
14
Period of Report
2019-11-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d819557d8k.htm   iXBRL 8-K 38715
2 EX-99.1 d819557dex991.htm EX-99.1 11556
6 GRAPHIC g819557g46w11.jpg GRAPHIC 6975
  Complete submission text file 0001193125-19-290995.txt   191391

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nvta-20191108.xsd EX-101.SCH 3069
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvta-20191108_lab.xml EX-101.LAB 18125
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvta-20191108_pre.xml EX-101.PRE 11405
11 EXTRACTED XBRL INSTANCE DOCUMENT d819557d8k_htm.xml XML 3388
Mailing Address 1400 16TH STREET SAN FRANCISCO CA 94103
Business Address 1400 16TH STREET SAN FRANCISCO CA 94103 (415) 374-7782
Invitae Corp (Filer) CIK: 0001501134 (see all company filings)

IRS No.: 271701898 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36847 | Film No.: 191214043
SIC: 8071 Services-Medical Laboratories